Survival outcomes of east Asian patients with advanced non‐small cell lung cancer treated with first‐line EGFR tyrosine kinase inhibitors: A network meta‐analysis of real‐world evidence

Abstract Background The comparative efficacies of different generation tyrosine kinase inhibitors (TKIs) in epidermal growth factor receptor (EGFR)‐mutated advanced non‐small cell lung cancer (NSCLC) remain largely unknown. Moreover, whether one EGFR‐TKI confers superior survival remains unclear, es...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Huang‐Chih Chang, Kuo‐Tung Huang, Chia‐Cheng Tseng, Yu‐Mu Chen, Chien‐Hao Lai, Yu‐Ping Chang, Yung‐Che Chen, Hung‐Yi Chuang, Chin‐Chou Wang
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2023-11-01
coleção:	Thoracic Cancer
Assuntos:	first‐line EGFR‐TKI network meta‐analysis non‐small cell lung cancer overall survival
Acesso em linha:	https://doi.org/10.1111/1759-7714.15112
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!